Study: Nalls, 2014

Population Ethnicity Diagnosis Source # Cases (% women) # Controls (% women) AAO (sd) AAO range AAE (sd) AAE range Ctrl age (sd) Ctrl age range # Polymorphisms
USA (CHARGE-CHS) C self-report, ICD-9, medications PO 107 (45%) 3164 (61%) 73 (5) - - - 72 (5) - 9,655

Polymorphisms in this population [-]

Polymorphism Location (hg19) Gene Allele contrast Ethnicity # Studies # Samples 1000G CEU 1000G CHB+JPT Meta OR (95%CI) I2 (95%CI) Meta P-value
rs58046886 chr20:3168430 DDRGK1 [-2566bp] A vs. G All: C 15 108,990 - - 1.09 (1.06-1.13) 38 (0-66) 5.99e-08
rs56981937 chr20:3168631 DDRGK1 [-2365bp] A vs. G All: C 15 108,990 - - 1.09 (1.06-1.13) 34 (0-64) 2.31e-07
rs1056881 chr20:3169729 DDRGK1 [-1267bp] A vs. G All: C 15 108,990 0.442 (A) 0.292 (G) 0.91 (0.88-0.94) 33 (0-64) 5.84e-08
rs4815574 chr20:3170172 DDRGK1 [-824bp] C vs. T All: C 15 108,990 0.442 (C) 0.283 (T) 0.92 (0.89-0.95) 32 (0-63) 1.44e-07
rs2295546 chr20:3171628 DDRGK1 A vs. G All: C 15 108,990 0.367 (A) 0.383 (A) 0.93 (0.90-0.97) 39 (0-67) 6.70e-05
rs2295547 chr20:3172246 DDRGK1 C vs. A All: C 15 108,990 0.367 (C) 0.392 (C) 0.93 (0.90-0.97) 39 (0-67) 6.91e-05
rs67249524 chr20:3172584 DDRGK1 G vs. T All: C 15 108,990 0.367 (G) 0.383 (G) 0.93 (0.90-0.97) 39 (0-67) 6.98e-05
rs8119219 chr20:3173907 DDRGK1 C vs. T All: C 15 108,990 0.367 (C) 0.383 (C) 0.93 (0.90-0.97) 39 (0-67) 6.21e-05
rs6515773 chr20:3174105 DDRGK1 C vs. T All: C 15 108,990 - - 1.07 (1.04-1.11) 39 (0-67) 8.11e-05
rs7274047 chr20:3174268 DDRGK1 C vs. T All: C 15 108,990 - - 1.07 (1.04-1.11) 39 (0-67) 6.30e-05
rs2295548 chr20:3175260 DDRGK1 T vs. C All: C 15 108,990 0.367 (T) 0.383 (T) 0.93 (0.90-0.97) 39 (0-67) 6.45e-05
rs2295551 chr20:3175742 DDRGK1 G vs. A All: C 15 108,990 0.367 (G) 0.383 (G) 0.93 (0.90-0.97) 39 (0-67) 6.98e-05
rs77811530 chr20:3213862 SLC4A11 G vs. A All: C 15 108,990 0.075 (G) - 0.94 (0.89-1.00) 0 (0-12) 0.039
rs117725082 chr20:3213909 SLC4A11 A vs. G All: C 15 108,990 0.033 (A) - 0.90 (0.83-0.98) 0 (0-20) 0.011
rs118130809 chr20:3215826 SLC4A11 C vs. T All: C 15 108,990 0.075 (C) - 0.94 (0.89-0.99) 0 (0-12) 0.028
rs78722238 chr20:3218029 SLC4A11 C vs. T All: C 15 108,990 0.075 (C) - 0.94 (0.89-0.99) 0 (0-14) 0.029
rs7264098 chr20:3289751 C20orf194 A vs. G All: C 14 106,227 0.075 (A) - 0.95 (0.89-1.01) 0 (0-29) 0.070
rs2280094 chr20:3653709 ADAM33 A vs. C All: C 15 108,990 0.2 (A) 0.042 (A) 1.07 (1.03-1.11) 0 (-) 7.64e-04
rs12214434 chr20:22836875 intergenic T vs. C All: C 15 108,990 - - 1.17 (1.07-1.27) 0 (0-35) 3.90e-04
rs76209012 chr20:25275266 PYGB C vs. T All: C 14 103,470 0.025 (C) - 1.28 (1.13-1.45) 12 (0-50) 1.38e-04
rs116944367 chr20:25515309 NINL A vs. G All: C 14 103,470 0.042 (A) - 1.27 (1.13-1.42) 28 (0-62) 7.82e-05
rs141718558 chr20:25539937 NINL C vs. T All: C 14 103,470 - - 0.79 (0.71-0.89) 33 (0-65) 6.59e-05
rs55726583 chr20:26173375 intergenic T vs. C All: C 14 105,052 - - 1.12 (1.06-1.18) 0 (0-48) 2.35e-05
rs6051217 chr20:26178568 intergenic G vs. T All: C 14 105,052 0.233 (G) 0.333 (G) 0.90 (0.85-0.94) 0 (0-48) 2.63e-05
rs17815267 chr21:39365472 DSCR4 A vs. G All: C 15 108,990 0.192 (A) - 1.11 (1.06-1.17) 2 (0-54) 1.15e-05
rs2836102 chr21:39366808 DSCR4 C vs. T All: C 15 108,990 0.192 (C) - 1.11 (1.06-1.17) 0 (0-53) 8.28e-06
rs12483064 chr21:41874160 DSCAM C vs. T All: C 15 108,990 0.108 (C) 0.05 (C) 1.09 (1.04-1.15) 4 (0-56) 6.99e-04
rs2837662 chr21:41877361 DSCAM G vs. T All: C 15 108,990 0.108 (G) - 1.10 (1.04-1.15) 1 (0-54) 4.97e-04
rs2837670 chr21:41894896 DSCAM C vs. T All: C 15 108,990 0.1 (C) 0.058 (C) 1.14 (1.07-1.21) 0 (0-49) 8.83e-05
rs77446120 chr21:41900869 DSCAM C vs. T All: C 15 108,990 - - 0.89 (0.83-0.94) 10 (0-47) 8.18e-05
rs8132937 chr21:43427492 ZBTB21 G vs. A All: C 15 108,990 0.4 (G) 0.133 (A) 0.94 (0.91-0.97) 0 (0-51) 1.28e-04
rs399907 chr21:43429646 ZBTB21 G vs. A All: C 15 108,990 0.358 (G) 0.133 (A) 0.93 (0.90-0.97) 14 (0-52) 8.31e-05
rs6586350 chr21:44239035 WDR4 [-24169bp] C vs. A All: C 15 108,990 0.342 (C) - 1.08 (1.04-1.12) 0 (0-48) 1.52e-05
rs6586351 chr21:44239062 WDR4 [-24142bp] G vs. A All: C 15 108,990 0.35 (G) - 1.08 (1.04-1.12) 0 (0-47) 1.43e-05
rs3788040 chr21:44289457 WDR4 C vs. T All: C 15 108,990 0.317 (C) 0.3 (T) 0.95 (0.92-0.98) 0 (0-42) 5.74e-04
rs3761379 chr21:44300780 NDUFV3 C vs. T All: C 15 108,990 0.333 (C) 0.3 (T) 0.94 (0.91-0.97) 0 (0-51) 9.30e-05
rs1041452 chr21:44316286 NDUFV3 T vs. C All: C 15 108,990 - - 1.07 (1.03-1.11) 11 (0-49) 7.89e-05
rs2187246 chr21:44326317 NDUFV3 C vs. T All: C 15 108,990 0.317 (C) 0.3 (T) 0.94 (0.91-0.97) 2 (0-54) 1.62e-04
rs4148976 chr21:44328830 NDUFV3 G vs. A All: C 15 108,990 - - 1.07 (1.04-1.11) 13 (0-51) 6.53e-05
rs71320572 chr21:44333169 NDUFV3 G vs. A All: C 15 108,990 - - 0.92 (0.89-0.96) 30 (0-62) 1.36e-05
rs2839605 chr21:44338212 NDUFV3 [+4798bp] C vs. T All: C 15 108,990 0.317 (C) 0.267 (T) 0.94 (0.91-0.97) 3 (0-55) 1.17e-04
rs8127471 chr21:44344090 NDUFV3 [+10676bp] T vs. C All: C 15 108,990 0.317 (T) 0.3 (C) 0.94 (0.91-0.97) 5 (0-56) 7.48e-05
rs6586265 chr21:44345180 NDUFV3 [+11766bp] T vs. C All: C 15 108,990 - - 1.07 (1.04-1.11) 0 (0-51) 4.13e-05
rs7276126 chr21:44345320 NDUFV3 [+11906bp] T vs. G All: C 15 108,990 - - 1.07 (1.04-1.11) 0 (0-52) 3.19e-05
rs9979193 chr21:44346385 NDUFV3 [+12971bp] G vs. A All: C 15 108,990 0.317 (G) 0.3 (A) 0.93 (0.90-0.96) 4 (0-56) 2.40e-05
rs13049906 chr21:44346705 NDUFV3 [+13291bp] C vs. A All: C 15 108,990 - - 1.07 (1.04-1.11) 7 (0-57) 2.59e-05
rs8129176 chr21:44347011 NDUFV3 [+13597bp] A vs. C All: C 15 108,990 - - 1.07 (1.04-1.11) 2 (0-55) 3.14e-05
rs8128260 chr21:44347082 NDUFV3 [+13668bp] T vs. G All: C 15 108,990 - - 1.07 (1.04-1.11) 3 (0-55) 2.78e-05
rs13046174 chr21:44348243 NDUFV3 [+14829bp] G vs. A All: C 15 108,990 0.325 (G) 0.292 (A) 0.93 (0.90-0.96) 5 (0-56) 2.74e-05
rs13046774 chr21:44348762 NDUFV3 [+15348bp] T vs. C All: C 15 108,990 0.35 (T) 0.3 (C) 0.93 (0.90-0.96) 1 (0-54) 2.96e-05